Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
Outcome of Infant Bacterial Therapeutics’ rights issue
February 2, 2018
To access the press release, please read the following disclaimer
here
.
Latest press releases
2024-12-20 16:33
IBT Continues Development of Drug Candidate IBP-9414
2024-11-14 08:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – September 30, 2024
Regulatory
2024-10-23 09:00
Infant Bacterial Therapeutics to present at FDA workshop in the USA
2024-10-09 09:00
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2025
Regulatory
2024-09-01 19:27
IBT invites you to a virtual meeting/call on Tuesday, September 3rd, 2024, at 4 pm CET, to discuss the recent results from the Connection Study.